Total Payments
$3,842
2024 Payments
$975.38
Companies
34
Transactions
240
Medicare Patients
2,261
Medicare Billing
$125,209
Payment Breakdown by Category
Food & Beverage$3,842 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,842 | 240 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $670.91 | 51 | $0 (2024) |
| Lilly USA, LLC | $580.15 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $516.38 | 31 | $0 (2024) |
| ABBVIE INC. | $444.83 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $242.93 | 13 | $0 (2024) |
| Amgen Inc. | $146.16 | 10 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $127.21 | 7 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $114.29 | 7 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $101.24 | 5 | $0 (2022) |
| GlaxoSmithKline, LLC. | $90.50 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $975.38 | 52 | Lilly USA, LLC ($277.56) |
| 2023 | $1,014 | 69 | Novo Nordisk Inc ($216.51) |
| 2022 | $866.19 | 50 | Novo Nordisk Inc ($196.78) |
| 2021 | $986.81 | 69 | AstraZeneca Pharmaceuticals LP ($173.70) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $59.73 | General |
| Category: Dermatology | ||||||
| 08/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardio-renal | ||||||
| 08/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.80 | General |
| 07/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Inflammation | ||||||
| 07/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Biological | ||||||
| 07/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Diabetes | ||||||
| 07/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $27.56 | General |
| 06/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardio-renal | ||||||
| 06/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Respiratory | ||||||
| 06/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Inflammation | ||||||
| 05/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Oncology | ||||||
| 05/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Obesity | ||||||
| 05/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 412 | 1,205 | $67,842 | $26,280 |
| 2022 | 7 | 540 | 1,439 | $78,963 | $31,814 |
| 2021 | 9 | 523 | 1,268 | $75,953 | $29,799 |
| 2020 | 10 | 786 | 1,713 | $109,730 | $37,317 |
Total Patients
2,261
Total Services
5,625
Medicare Billing
$125,209
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 372 | $34,968 | $17,372 | 49.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $14,445 | $4,671 | 32.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 72 | 286 | $10,296 | $2,229 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $1,740 | $655.71 | 37.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $1,896 | $573.12 | 30.2% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 11 | 11 | $363.00 | $348.92 | 96.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 36 | 183 | $1,830 | $188.94 | 10.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 48 | 260 | $1,560 | $188.05 | 12.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 24 | $744.00 | $52.80 | 7.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 195 | 434 | $40,796 | $20,921 | 51.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $16,371 | $5,449 | 33.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 112 | 341 | $12,276 | $2,755 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 28 | $4,060 | $2,081 | 51.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 67 | 225 | $2,250 | $262.04 | 11.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 62 | 318 | $1,908 | $251.61 | 13.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 28 | 42 | $1,302 | $93.31 | 7.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 185 | 419 | $39,386 | $19,279 | 48.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 58 | 58 | $18,618 | $6,328 | 34.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 95 | 234 | $8,424 | $1,694 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 27 | $3,915 | $1,439 | 36.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $560.00 | $260.16 | 46.5% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 13 | 13 | $260.00 | $258.83 | 99.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 58 | 307 | $1,842 | $251.68 | 13.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 45 | 146 | $1,460 | $180.03 | 12.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 30 | 48 | $1,488 | $108.00 | 7.3% |
About Heather Dyer
Heather Dyer is a Primary Care healthcare provider based in Southern Pines, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2016. The National Provider Identifier (NPI) number assigned to this provider is 1528500444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Dyer has received a total of $3,842 in payments from pharmaceutical and medical device companies, with $975.38 received in 2024. These payments were reported across 240 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,842).
As a Medicare-enrolled provider, Dyer has provided services to 2,261 Medicare beneficiaries, totaling 5,625 services with total Medicare billing of $125,209. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Location Southern Pines, NC
- Active Since 11/09/2016
- Last Updated 09/29/2020
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1528500444
Products in Payments
- FARXIGA (Drug) $325.50
- JARDIANCE (Drug) $313.96
- Ozempic (Drug) $308.74
- VRAYLAR (Drug) $293.15
- BREZTRI (Drug) $190.88
- ZEPBOUND (Drug) $168.40
- Rybelsus (Drug) $153.62
- Wegovy (Drug) $134.40
- MOUNJARO (Drug) $129.05
- TRINTELLIX (Drug) $127.21
- XIFAXAN (Drug) $114.29
- TRELEGY ELLIPTA (Drug) $90.50
- Edarbyclor (Drug) $81.94
- PROCLAIM (Device) $75.86
- Kerendia (Drug) $75.06
- Cologuard Collection Kit (Device) $74.27
- UBRELVY (Drug) $71.05
- Edarbi (Drug) $67.88
- NURTEC ODT (Drug) $64.94
- EMGALITY (Drug) $60.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Southern Pines
Karen Patterson, Dnp, Agpcnp, DNP, AGPCNP
Primary Care — Payments: $3,114
Primary Care $3,114
Chelsi Frazer
Primary Care — Payments: $638.52
Primary Care $638.52
David Mcdonald, Fnp, FNP
Primary Care — Payments: $455.62
Primary Care $455.62
Ms. Lu Cromartie, Anp, ANP
Primary Care — Payments: $249.83
Primary Care $249.83